|
DR. ABRAHAM SARTANI has served as a Director of the Company since October 2006 and is the chairman of our compensation and stock option committee and a member of our audit committee. Dr. Sartani has been a non-executive member of the board of directors of LWC since May 2003. Since April 1980, Dr. Sartani has been involved with the business and commercial aspects of medicine and drug development and has filled various executive positions in pharmaceutical companies in Italy. In September 1985, Dr. Sartani was appointed Medical Director at Recordati S.p.A., one of the largest pharmaceutical companies in Italy. He was later promoted to become the head of the Pharmaceutical Research & Development division, a position he currently retains. From 1999, he has been responsible for Recordati's licensing activities. Dr. Sartani has published numerous scientific papers and is a co-inventor of several patents. Together with other members of his team, he was awarded the Atomo d'Oro award in 1993 and the Premio Galeno award in 1994. Dr. Sartani is also a member of the board of directors of LWC, Pharmos Inc., Can Fite Biopharma Ltd., and Nanopass Technologies Ltd. He is a member of prominent scientific organizations, including the New York Academy of Sciences, the International Association for the Study of Pain, the American Management Association and he is also a Fellow of the Royal Society of Medicine. Dr. Sartani received his medical education at the Universities of Tel Aviv and Bologna and his specialist (cum laude) degree in Endocrinology at the University of Pavia. | 